A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer

NCT00796718 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

RADIATION: Standard radiotherapy
DRUG: Capecitabine [Xeloda]

Sponsor

Hoffmann-La Roche